title: Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
authors.forename: Benedetta
authors.initials: B
authors.lastname: Belloni
authors.forename: Mahzad
authors.initials: M
authors.lastname: Ziai
authors.forename: Annick
authors.initials: A
authors.lastname: Lim
authors.forename: Brigitte
authors.initials: B
authors.lastname: Lemercier
authors.forename: Martin
authors.initials: M
authors.lastname: Sbornik
authors.forename: Stephan
authors.initials: S
authors.lastname: Weidinger
authors.forename: Christian
authors.initials: C
authors.lastname: Andres
authors.forename: Christina
authors.initials: C
authors.lastname: Schnopp
authors.forename: Johannes
authors.initials: J
authors.lastname: Ring
authors.forename: Rüdiger
authors.initials: R
authors.lastname: Hein
authors.forename: Markus
authors.initials: M
authors.lastname: Ollert
authors.forename: Martin
authors.initials: M
authors.lastname: Mempel
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000187:drug effects* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C026408:anti-IgE antibodies; D000069444:Omalizumab; D007073:Immunoglobulin E